How were Axcella Health's earnings last quarter?

Axcella Health Inc. (NASDAQ:AXLA) posted its quarterly earnings data on Wednesday, November, 10th. The company reported ($10.25) earnings per share for the quarter, topping analysts' consensus estimates of ($11.25) by $1.00.

When did Axcella Health's stock split?

Axcella Health's stock reverse split on Tuesday, September 19th 2023. The 1-25 reverse split was announced on Thursday, September 14th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, September 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

What is Bill Hinshaw's approval rating as Axcella Health's CEO?

5 employees have rated Axcella Health Chief Executive Officer Bill Hinshaw on Glassdoor.com . Bill Hinshaw has an approval rating of 100% among the company's employees. This puts Bill Hinshaw in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 77.0% of employees surveyed would recommend working at Axcella Health to a friend.

What other stocks do shareholders of Axcella Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axcella Health investors own include Sorrento Therapeutics (SRNE) , VBI Vaccines (VBIV) , Evofem Biosciences (EVFM) , ADMA Biologics (ADMA) , Coty (COTY) , Energy Transfer (ET) , Myovant Sciences (MYOV) , NVIDIA (NVDA) , Pfizer (PFE) and Moderna (MRNA) .

When did Axcella Health IPO?

Axcella Health (AXLA) raised $76 million in an initial public offering on Thursday, May 9th 2019. The company issued 3,600,000 shares at $20.00-$22.00 per share. Goldman Sachs, J.P. Morgan and SVB Leerink acted as the underwriters for the IPO.

NASDAQ:AXLA

Axcella Health (AXLA) Stock Price, News & Analysis

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

Free AXLA Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $0.36
▼
$0.51
50-Day Range: $0.40
▼
$4.58
52-Week Range: $0.34
▼
$41.25

Volume: 6,700 shs
Average Volume: 267,009 shs
Market Capitalization: $1.18 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Earnings Headlines Insider Trades Ownership Short Interest Social Media

Get Axcella Health alerts:

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About Axcella Health Stock (NASDAQ:AXLA)

Axcella Health Inc. operates as a clinical-stage biotechnology company in the United States. The company treats complex diseases using endogenous metabolic modulators. Its product pipeline includes AXA1125 that is in Phase 2a clinical trial for long COVID therapy for patients, as well as Phase 2b clinical trial for treating non-alcoholic steatohepatitis; and AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

AXLA Stock News Headlines

December 27, 2023 | bizjournals.com

Biotech layoffs 2023: In Q4, 11 companies laid off around 500 people

December 25, 2023 | bizjournals.com

Year in Review: Here are the top stories in Boston-area life sciences in 2023

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

December 5, 2023 | msn.com

Axcella Health to close

December 5, 2023 | bizjournals.com

Flagship spinout Axcella collapses, leaving future of its long Covid drug uncertain

November 7, 2023 | morningstar.com

Axcella Health Inc AXLA

November 1, 2023 | msn.com

Axcella Health (AXLA) Price Target Increased by 7971.00% to 15,870.09

September 29, 2023 | markets.businessinsider.com

Pre-market Movers: RLMD, BROG, VSME, AXLA, NKE…

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

September 15, 2023 | finance.yahoo.com

Are Medical Stocks Lagging Axcella Health (AXLA) This Year?

September 15, 2023 | finance.yahoo.com

Are Medical Stocks Lagging Axcella Health (AXLA) This Year?

September 15, 2023 | investorplace.com

Why Is Axcella Health (AXLA) Stock Down 24% Today?

September 15, 2023 | msn.com

Ford, GM shares fall on strike action, with ARM stock jumping post IPO and other shares on the move

September 14, 2023 | finance.yahoo.com

Axcella Announces Reverse Stock Split Effective September 19, 2023

September 5, 2023 | benzinga.com

Penny Stocks Stocks Poised To Pop On News (EPAZ, AXLA, NVOS, IQST)

August 30, 2023 | finance.yahoo.com

Are Medical Stocks Lagging Clover Health Investments (CLOV) This Year?

August 30, 2023 | benzinga.com

What's Going On With Axcella Health Stock This Week?

August 30, 2023 | finance.yahoo.com

Axcella (AXLA) Up on Patent Grant for Long Covid Fatigue Drug

August 30, 2023 | finance.yahoo.com

Are Medical Stocks Lagging Clover Health Investments (CLOV) This Year?

August 29, 2023 | benzinga.com

Axcella Health Stock Is Skyrocketing: What's Going On?

August 29, 2023 | proactiveinvestors.com

Axcella Health stock rockets on long Covid patent win

August 29, 2023 | finance.yahoo.com

Axcella Granted Patent for Long COVID Fatigue Treatment

August 29, 2023 | investorplace.com

Why Is Axcella Health (AXLA) Stock Up 280% Today?

May 8, 2023 | markets.businessinsider.com

Axcella Health (AXLA) Gets a Hold from H.C. Wainwright

April 17, 2023 | finance.yahoo.com

Axcella Announces Two Oral Presentations on AXA1125 for Long COVID Fatigue at ECCMID 2023

April 14, 2023 | finance.yahoo.com

Big Bank's Big Q1 Performance, Florida Gov. Quietly Slips 6-Week Abortion Ban Into Law, Subway Sandwich Seeks $10B Sale: Today's Top Stories

April 14, 2023 | msn.com

Long COVID-Fatigue Impacts 50M People - Axcella Health Seeks Funding To Support Drug Development

See More Headlines

Receive AXLA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Axcella Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/10/2021
Today: 4/18/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biological products, except diagnostic
Sub-Industry: N/A
Current Symbol: NASDAQ:AXLA
CUSIP: N/A
CIK: 1633070
Web: www.axcellahealth.com
Phone: (857) 320-2200
Fax: 617-441-6243
Employees: 11
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($19.25)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-81,190,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -259.91%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.80
Quick Ratio: 0.80

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.42 per share
Price / Book: 0.28

Miscellaneous

Outstanding Shares: 2,950,000
Free Float: 2,883,000
Market Cap: $1.18 million
Optionable: Optionable
Beta: 0.46

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Craig R. Jalbert CIRA (Age 61)
President, CEO, Treasurer, Secretary, Financial and Accounting Officer & Director
Dr. Alison D. Schecter M.D. (Age 58)
President of Strategy & Operations
Comp: $525.53k
Mr. David R. Epstein B.Sc. (Age 61)
M.B.A., Consultant
Comp: $228.34k
Mr. Dan Kirby
Senior Vice President of Strategic Operations
Marie Washburn
VP of Finance & Corporate Controller
Dr. Karim Azer Ph.D.
Vice President of Platform & Discovery

Key Competitors

View All Competitors

AXLA Stock Analysis - Frequently Asked Questions

How were Axcella Health's earnings last quarter?: Axcella Health Inc. (NASDAQ:AXLA) posted its quarterly earnings data on Wednesday, November, 10th. The company reported ($10.25) earnings per share for the quarter, topping analysts' consensus estimates of ($11.25) by $1.00.
When did Axcella Health's stock split?: Axcella Health's stock reverse split on Tuesday, September 19th 2023. The 1-25 reverse split was announced on Thursday, September 14th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, September 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.
What is Bill Hinshaw's approval rating as Axcella Health's CEO?: 5 employees have rated Axcella Health Chief Executive Officer Bill Hinshaw on Glassdoor.com. Bill Hinshaw has an approval rating of 100% among the company's employees. This puts Bill Hinshaw in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 77.0% of employees surveyed would recommend working at Axcella Health to a friend.

What other stocks do shareholders of Axcella Health own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Axcella Health investors own include Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), Evofem Biosciences (EVFM), ADMA Biologics (ADMA), Coty (COTY), Energy Transfer (ET), Myovant Sciences (MYOV), NVIDIA (NVDA), Pfizer (PFE) and Moderna (MRNA).
When did Axcella Health IPO?: Axcella Health (AXLA) raised $76 million in an initial public offering on Thursday, May 9th 2019. The company issued 3,600,000 shares at $20.00-$22.00 per share. Goldman Sachs, J.P. Morgan and SVB Leerink acted as the underwriters for the IPO.

This page (NASDAQ:AXLA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Axcella Health (AXLA) Stock Price, News & Analysis

About Axcella Health Stock (NASDAQ:AXLA)

AXLA Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

AXLA Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info